DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Valiant Laboratories Limited — Outcome of Board Meeting

NSE 1 hr ago·10 Aug 2026, 2:51 pm

Valiant Laboratories

Valiant Laboratories Limited has informed the stock exchange that its board has approved the financial results for the period ended June 30, 2026. This announcement is a routine corporate disclosure required by market regulations to keep investors informed about the company's performance.

For investors, this update provides the first official data on the company's financial health for the new fiscal year. It offers a snapshot of operational efficiency and profitability, which are key factors in assessing the stock's current value.

Investors should look for a comparison of revenue and profit figures against the previous year. Any significant deviation from expectations will likely influence the stock's short-term price movement.